SIG up +1.87% percent right now. $SIG High is at 123.45 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
SIG up +1.87% percent right now. $SIG High is at 123.45 and the Low 119.90 with current volume of 523,697.

Recent News posted below.

SIG Signet Jewelers Limited Recent Headline News

Signet Jewelers
at Investor's Business Daily - Fri Oct 24, 5:27PM CDT
Signet Jewelers (SIG) got a $133 price target by Nomura Securities after speaking with the CEO and CFO, both of whom are new. Shares rose 2.5% to 115.83.
SIG: 122.48 (+2.19)

After Yesterday's Rally of 2.47% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Oct 24, 5:21PM CDT
Signet Jewelers (NYSE:SIG) traded in a range yesterday that spanned from a low of $112.78 to a high of $116.22. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $113.99 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SIG: 122.48 (+2.19)

Signet Jewelers 'Most Compelling' In Retail: Analyst
at Investor's Business Daily - Fri Oct 24, 12:23PM CDT
Despite losing its top two executives recently, Signet Jewelers (SIG) "remains among the most compelling multiyear stories in retail," said Nomura Securities analyst Simeon Siegel in a research note Friday. After meeting with newly named CEO Mark...
NILE: 35.25 (-0.55), TIF: 99.64 (+0.78), SIG: 122.48 (+2.19)

Watch for Signet Jewelers to Potentially Rebound After Falling 3.31% Yesterday
Comtex SmarTrend(R) - Tue Oct 14, 4:32PM CDT
Signet Jewelers (NYSE:SIG) traded in a range yesterday that spanned from a low of $102.06 to a high of $106.53. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of $107.00 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SIG: 122.48 (+2.19)

Why Signet Jewelers (SIG) Stock Is Down Today
at The Street - Tue Oct 14, 10:30AM CDT
Signet Jewelers (SIG) is falling Tuesday after announcing that CEO Michael Barnes will resign.
SIG: 122.48 (+2.19)

Signet Jewelers Announces New CEO
Marketwired - Tue Oct 14, 7:05AM CDT
Signet Jewelers Limited ("Signet" (NYSE: SIG) (LSE: SIG), the largest specialty jewelry retailer in the US, UK and Canada, today announced that Michael Barnes has resigned from his position as Chief Executive Officer and from Signet's board of directors, effective October 31, 2014, and Mark Light, currently Signet's President and Chief Operating Officer, will succeed Mr. Barnes as Chief Executive Officer of Signet following his departure and will also join Signet's board of directors. Signet is also reaffirming its financial guidance initiated in its second quarter earnings release on August 28, 2014.
SIG: 122.48 (+2.19)

Signet Jewelers Set to Possibly Rebound After Yesterday's Selloff of 1.29%
Comtex SmarTrend(R) - Wed Oct 08, 4:33PM CDT
Signet Jewelers (NYSE:SIG) traded in a range yesterday that spanned from a low of $110.94 to a high of $114.02. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $113.04 on volume of 1.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SIG: 122.48 (+2.19)

Is It Time to Buy Tiffany Stock?
Andrés Cardenal, The Motley Fool - Motley Fool - Mon Oct 06, 3:30PM CDT
Source: Tiffany Tiffany stock has delivered sparkling performance for investors lately, rising by more than 25% over the last year on the back of rock-solid financial performance and shining opportunities for growth in emerging markets. However,...
COH: 33.71 (+0.05), KORS: 69.73 (-0.22), TIF: 99.64 (+0.78), MUSA: 59.18 (-0.23), AAPL: 108.97 (-0.04), SIG: 122.48 (+2.19), LULU: 42.98 (-0.78)

Look for Shares of Signet Jewelers to Potentially Rebound after Yesterday's 1.18% Sell Off
Comtex SmarTrend(R) - Tue Sep 23, 5:21PM CDT
Signet Jewelers (NYSE:SIG) traded in a range yesterday that spanned from a low of $112.83 to a high of $114.56. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $114.04 on volume of 964,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SIG: 122.48 (+2.19)

2 Jewelry Retailers for the Long Run - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 1:07PM CDT
Are Signet (SIG) and Tiffany (TIF) part of your portfolio? Well, given their underlying factors and the nearing holiday season, these stocks may be prominent picks.
TIF: 99.64 (+0.78), SIG: 122.48 (+2.19)

Tiffany's (TIF) to Issue Senior Notes Worth $550 Million - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 11:50AM CDT
Jewelry retailer, Tiffany & Co. (TIF) announced the pricing of two senior notes worth $550 million for private offering.
CTRN: 22.14 (+0.34), TIF: 99.64 (+0.78), FL: 54.47 (-0.03), SIG: 122.47 (+2.18)

Notice of Announcement Fiscal 2015 Third Quarter Financial Results
Marketwire - Wed Sep 17, 8:01AM CDT
Signet Jewelers Limited ("Signet" (NYSE: SIG) (LSE: SIG), intends to announce its results for the 13 and 39 weeks ended November 1, 2014 at approximately 7:00 a.m. ET on Tuesday, November 25, 2014.
SIG: 122.47 (+2.18)

Tiffany Keeps Earnings Momentum, Soft Japan Sales a Pain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 3:10PM CDT
Tiffany (TIF) sustained its positive earnings surprise for the second consecutive quarter in fiscal 2014 hinting that the company is gradually regaining sheen.
LAD: 74.31 (-1.34), CTRN: 22.14 (+0.34), TIF: 99.64 (+0.78), SIG: 122.47 (+2.18)

Which Specialty Retail Stocks Whet Investor Appetite?
at Investor's Business Daily - Mon Sep 15, 12:51PM CDT
Signet Jewelers (SIG) and Gap (GPS) are among Sterne Agee analyst Ike Boruchow's best recommendations as he checks out same-store sales, margins and inventory positions in specialty retail for the industry's crucial second half. After trailing much...
FOSL: 103.44 (+0.43), FL: 54.47 (-0.03), TIF: 99.64 (+0.78), GPS: 38.53 (-0.30), FINL: 26.07 (-0.50), SIG: 122.47 (+2.18)

Home Depot Hits 52 Week High on Solid Q2 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 9:40AM CDT
The Home Depot (HD) hit a 52-week high of $93.52 on the last trading day.
WWAV: 35.63 (-1.30), HD: 97.47 (-0.18), LOW: 57.80 (+0.11), SIG: 122.47 (+2.18)

Signet Shows Promise Post Q2: Is SIG Part of Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 9:00AM CDT
Signet (SIG) holds a Zacks Rank #1 (Strong Buy) and has surged roughly 51% year to date, demonstrating its inherent strength and long-term earnings growth projection of 8%.
LAD: 74.31 (-1.34), CTRN: 22.14 (+0.34), TIF: 99.64 (+0.78), SIG: 122.47 (+2.18)

Earnings Releases, Receipt of Required Permit, CSR Programs - Research Reports on Signet, Abercrombie & Fitch, Las Vegas Sands, Best Buy and Lowe's
PR Newswire - Tue Sep 02, 7:40AM CDT
Today, Analysts Review released its research reports regarding Signet Jewelers Limited (NYSE: SIG), Abercrombie & Fitch Co. (NYSE: ANF), Las Vegas Sands Corp. (NYSE: LVS), Best Buy Co., Inc. (NYSE: BBY) and Lowe's Companies Inc. (NYSE: LOW). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6145-100free.
ANF: 28.53 (-0.97), BBY: 34.80 (-0.38), LOW: 57.80 (+0.11), LVS: 59.58 (+0.05), SIG: 122.47 (+2.18)

Late Burst Propels Stocks To Strong Finish
at Investor's Business Daily - Fri Aug 29, 4:16PM CDT
A burst of buying in the final half-hour of trading lifted stocks, providing a positive punctuation mark for Friday and the preholiday week. The Nasdaq finished a fifth straight up week with a daily gain of 0.5% and at a 14-year high. The S&P 500...
CONN: 31.24 (-0.87), SIG: 122.47 (+2.18), AVGO: 85.48 (+0.44)

Late Spurt Boosts Stocks To Finish Up For Week
at Investor's Business Daily - Fri Aug 29, 3:50PM CDT
A last-hour burst Friday put stocks further into positive territory, capping a fourth straight weekly advance for the Nasdaq. Volume was lighter on both exchanges. In the stock market today, chipmaker Avago Technologies (AVGO) was up more than 7% in...
VIPS: 24.47 (+1.13), FANG: 67.86 (-1.63), SIG: 122.47 (+2.18), AVGO: 85.48 (+0.44)

Luxury Stocks Take Hit, From Furnishings To Fashion
at Investor's Business Daily - Fri Aug 29, 1:48PM CDT
Except for two jewelers, it was not a good week for luxury stocks. Shares of luxury names from home goods and furnishings to fashion and watches stumbled, with the sharpest drops seen from Williams-Sonoma (WSM) and Movado (MOV) following their...
RH: 77.19 (-0.41), TIF: 99.64 (+0.78), KORS: 69.73 (-0.22), WSM: 66.46 (+0.58), MOV: 36.91 (-0.20), SIG: 122.44 (+2.15)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Horizons: Future of IVD Contract Manufacturing

Updated Category News Views 117

The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...

Continue Reading
Citi Upgrades AerCap Holdings Price Target to $117 Amid Strong Performance

Updated Category News Views 79

Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...

Continue Reading
LG Energy Solution Reports Strong Q2 2025 Financial Performance

Updated Category News Views 750

LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...

Continue Reading
Genpact Shines as a Leader in Sustainability Recognition

Updated Category News Views 264

Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 344

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading